Innovative drug concept stocks saw unusual surges, with Maiwei Biotech and Beigene hitting new highs during the trading session
Innovative drug concept stocks experienced a surge, with Maiwei Biotech and Beigene hitting new highs during the session. Baihua Medicine reached the daily limit, Zhixiang Jintai rose over 10%, and Kangchen Pharmaceutical, Changchun Gaoxin, Wohu Biotech, Jibeier, and Puris also followed suit. In related ETFs, the Innovative Drug ETF from Guotai rose by 0.98%, with a trading volume of 4.1062 million yuan, while the Innovative Drug ETF from Fuguo increased by 0.93%, with a trading volume of 10.3808 million yuan
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments